Fabhalta (iptacopan)
- Drug Name: Fabhalta
- Generic Name: Iptacopan
- Dosage Forms and Strengths: Capsules: 200 mg
- Manufactured by: Novartis Pharmaceuticals Corporation
A complement factor B inhibitor called FABHALTA is recommended for the management of adults suffering with paroxysmal nocturnal hemoglobinuria (PNH).
Recommended Dosage:
200 mg orally twice daily with or without food.
- Tracking PNH Symptoms Following FABHALTA Discontinuation: After stopping, keep an eye out for any hemolysis symptoms.
- Hyperlipidemia: If necessary, start taking cholesterol-lowering medicine and periodically check blood lipid parameters while receiving treatment.
If you are considering the import of Fabhalta (iptacopan) to India, please be aware that Fabhalta can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:
Required Documentation for Import:
- A valid prescription from a qualified medical practitioner.
- Diagnostic reports of the patient.
- Government-issued identification proof for the patient, as recognized by the Government of India.
Order Confirmation Process:
The order for Fabhalta (iptacopan) will be confirmed upon the receipt of the following documents:
- A valid prescription from a qualified doctor.
- An import permit, if applicable.
Availability of Fabhalta in India:
Fabhalta (iptacopan) is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.
Fabhalta (iptacopan) can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.
- IPN (Indian Pharma Network) is dedicated to facilitating the supply of Fabhalta (iptacopan)
- (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.
- For inquiries regarding the price of Fabhalta (iptacopan) in India and to initiate the ordering process, please reach out to us through the following contact details:
- Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.
Indian Pharma Network is proficient in sourcing Fabhalta (iptacopan) from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.
Monitoring PNH symptoms post-discontinuation of Fabhalta is advised. Patients should be vigilant for any signs of hemolysis. Additionally, hyperlipidemia might occur, necessitating cholesterol-lowering medication and regular lipid parameter checks during treatment.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.